Article
Distinct medical and substance use histories associate with cognitive decline in Alzheimer’s Disease
2024-11-28
Abstract excerpt
<h4>INTRODUCTION</h4> Phenotype clustering reduces patient heterogeneity and could be useful when designing precision clinical trials. We hypothesized that the onset of early cognitive decline in patients would exhibit variance predicated on the clinical history documented prior to an Alzheimer’s Disease (AD) diagnosis <h4>METHODS</h4> Self-reported medical and substance use history (i.e., problem history) was use...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7641e0bb-bcb9-5ae4-9a06-3b95d42449e5
- DOI
- 10.1101/2024.11.26.24317918
